These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 17440426

  • 1. Radioimmunotherapy with astatine-211 using chimeric monoclonal antibody U36 in head and neck squamous cell carcinoma.
    Cheng J, Ekberg T, Engström M, Nestor M, Jensen HJ, Tolmachev V, Anniko M.
    Laryngoscope; 2007 Jun; 117(6):1013-8. PubMed ID: 17440426
    [Abstract] [Full Text] [Related]

  • 2. Targeting of a head and neck squamous cell carcinoma xenograft model using the chimeric monoclonal antibody U36 radioiodinated with a closo-dodecaborate-containing linker.
    Cheng J, Persson M, Tolmachev V, Siavaev I, Orlova A, Kairemo K, Anniko M.
    Acta Otolaryngol; 2004 Nov; 124(9):1078-85. PubMed ID: 15513553
    [Abstract] [Full Text] [Related]

  • 3. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.
    Tijink BM, Neri D, Leemans CR, Budde M, Dinkelborg LM, Stigter-van Walsum M, Zardi L, van Dongen GA.
    J Nucl Med; 2006 Jul; 47(7):1127-35. PubMed ID: 16818947
    [Abstract] [Full Text] [Related]

  • 4. Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck.
    Colnot DR, Quak JJ, Roos JC, van Lingen A, Wilhelm AJ, van Kamp GJ, Huijgens PC, Snow GB, van Dongen GA.
    J Nucl Med; 2000 Dec; 41(12):1999-2010. PubMed ID: 11138685
    [Abstract] [Full Text] [Related]

  • 5. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
    Bäck T, Andersson H, Divgi CR, Hultborn R, Jensen H, Lindegren S, Palm S, Jacobsson L.
    J Nucl Med; 2005 Dec; 46(12):2061-7. PubMed ID: 16330571
    [Abstract] [Full Text] [Related]

  • 6. 186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts.
    Gerretsen M, Visser GW, van Walsum M, Meijer CJ, Snow GB, van Dongen GA.
    Cancer Res; 1993 Aug 01; 53(15):3524-9. PubMed ID: 8339258
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics, biodistribution, and dosimetry of specific and control radiolabeled monoclonal antibodies in patients with primary head and neck squamous cell carcinoma.
    Maraveyas A, Stafford N, Rowlinson-Busza G, Stewart JS, Epenetos AA.
    Cancer Res; 1995 Mar 01; 55(5):1060-9. PubMed ID: 7866989
    [Abstract] [Full Text] [Related]

  • 11. Astatine-211-labeled antibodies for treatment of disseminated ovarian cancer: an overview of results in an ovarian tumor model.
    Andersson H, Elgqvist J, Horvath G, Hultborn R, Jacobsson L, Jensen H, Karlsson B, Lindegren S, Palm S.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 2):3914S-21S. PubMed ID: 14506189
    [Abstract] [Full Text] [Related]

  • 12. Radioimmunotherapy of nude mice with intraperitoneally growing ovarian cancer xenograft utilizing 211At-labelled monoclonal antibody MOv18.
    Andersson H, Lindegren S, Back T, Jacobsson L, Leser G, Horvath G.
    Anticancer Res; 2000 Sep 01; 20(1A):459-62. PubMed ID: 10769696
    [Abstract] [Full Text] [Related]

  • 13. Effect of cetuximab in combination with alpha-radioimmunotherapy in cultured squamous cell carcinomas.
    Nestor M, Sundström M, Anniko M, Tolmachev V.
    Nucl Med Biol; 2011 Jan 01; 38(1):103-12. PubMed ID: 21220133
    [Abstract] [Full Text] [Related]

  • 14. Administered activity and metastatic cure probability during radioimmunotherapy of ovarian cancer in nude mice with 211At-MX35 F(ab')2.
    Elgqvist J, Andersson H, Bernhardt P, Bäck T, Claesson I, Hultborn R, Jensen H, Johansson BR, Lindegren S, Olsson M, Palm S, Warnhammar E, Jacobsson L.
    Int J Radiat Oncol Biol Phys; 2006 Nov 15; 66(4):1228-37. PubMed ID: 17145538
    [Abstract] [Full Text] [Related]

  • 15. The use of closo-dodecaborate-containing linker improves targeting of HNSCC xenografts with radioiodinated chimeric monoclonal antibody U36.
    Cheng J, Engstrom M, Ekberg T, Nestor M, Anniko M, Tolmachev V.
    Mol Med Rep; 2010 Nov 15; 3(1):155-60. PubMed ID: 21472215
    [Abstract] [Full Text] [Related]

  • 16. Locoregional alpha-radioimmunotherapy of intraperitoneal tumor cell dissemination using a tumor-specific monoclonal antibody.
    Huber R, Seidl C, Schmid E, Seidenschwang S, Becker KF, Schuhmacher C, Apostolidis C, Nikula T, Kremmer E, Schwaiger M, Senekowitsch-Schmidtke R.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 2):3922S-8S. PubMed ID: 14506190
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.
    Verel I, Visser GW, Boellaard R, Boerman OC, van Eerd J, Snow GB, Lammertsma AA, van Dongen GA.
    J Nucl Med; 2003 Oct 01; 44(10):1663-70. PubMed ID: 14530484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.